Search - tctmd.com

Displaying 1 - 14 of 14

Sort: Relevancy | Date

News Daily News

Top General Cardiology and Prevention News of 2024

Caitlin E. Cox

December 30, 2024

News Opinion CV Team Dispatch

August 2024 Dispatch for the CV Team

L.A. McKeown

August 01, 2024

News Daily News

Infective Endocarditis in Opioid Users: Care Must Go Beyond the Heart

Caitlin E. Cox

February 26, 2024

News Daily News

Infective Endocarditis Deaths Rise as Opioid Crisis Deepens

Caitlin E. Cox

December 14, 2023

News Daily News

Hormonal Birth Control, NSAID Use Together Linked to VTE

Caitlin E. Cox

September 11, 2023

News Features

Skyrocketing Popularity Puts GLP-1 Agonists for Weight Loss on Cardiology’s Radar

L.A. McKeown

May 12, 2023

News Daily News

SURMOUNT-1: Tirzepatide Drastically Reduces Weight in Obese Patients

L.A. McKeown

June 09, 2022

News Conference News EAS 2022

ROSE Trial: CETP Inhibitor Shows Promise as Oral Add-on for LDL-Lowering

Michael O'Riordan

May 24, 2022

News Features

Pricey Inclisiran Is Rolling Out: a ‘Buy-and-Bill’ Model May Smooth Its Path

Michael O'Riordan

January 17, 2022

News Daily News

TCTMD’s Top 10 Most Popular Stories for December 2021

Caitlin E. Cox

December 29, 2021

News Conference News ESC 2021

PRONOUNCE: No Difference in CVD Risks With Degarelix and Leuprolide for Prostate Cancer

Michael O'Riordan

August 30, 2021

News Daily News

Infective Endocarditis in IV Drug Users Doesn’t Always Match Expectations

Caitlin E. Cox

February 01, 2021

News Daily News

Inclisiran Data in NEJM Prompt Talk of What Comes Next

Caitlin E. Cox

March 24, 2020

News Daily News

Infective Endocarditis Related to Injecting Opioids on the Rise in Ontario

Todd Neale

January 28, 2019

Advertisement

Top General Cardiology and Prevention News of 2024

August 2024 Dispatch for the CV Team

Infective Endocarditis in Opioid Users: Care Must Go Beyond the Heart

Infective Endocarditis Deaths Rise as Opioid Crisis Deepens

Hormonal Birth Control, NSAID Use Together Linked to VTE

Skyrocketing Popularity Puts GLP-1 Agonists for Weight Loss on Cardiology’s Radar

SURMOUNT-1: Tirzepatide Drastically Reduces Weight in Obese Patients

ROSE Trial: CETP Inhibitor Shows Promise as Oral Add-on for LDL-Lowering

Pricey Inclisiran Is Rolling Out: a ‘Buy-and-Bill’ Model May Smooth Its Path

TCTMD’s Top 10 Most Popular Stories for December 2021

PRONOUNCE: No Difference in CVD Risks With Degarelix and Leuprolide for Prostate Cancer

Infective Endocarditis in IV Drug Users Doesn’t Always Match Expectations

Inclisiran Data in NEJM Prompt Talk of What Comes Next

Infective Endocarditis Related to Injecting Opioids on the Rise in Ontario

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content